YOLFTbeta
Diagnostic Medical Systems SA

Diagnostic Medical Systems SA

ALDMS · PA · Healthcare / Medical Devices

0.90EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.90
Open0.90
Day Range0.896 – 0.902
52-Week Range0.82 – 1.49
Volume22.80K
Market Cap23.87M
P/E (TTM)46.10
Forward P/E0.00
EPS0.02
Dividend Yield0.00%
Beta0.68
50-Day Avg1.03
200-Day Avg1.23

About

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafale DR, and !Mobile Wall Stand names; c-arm products under the EVO R+ FP ADAM and EVO + / EVO R+ names; retrofit kits; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Samuel Sancerni
  • Employees136
  • Headquarters9 Avenue du Canal Philippe Lamour, Gallargues-le-Montueux, France, 30 660, France
  • Websitehttps://www.dms-imaging.com

Leadership

  • Mr. Samuel SancerniChairman & CEO
  • Ms. Valerie PugnaloniDirector of Administrative & Financial
  • Mr. Jerome DelanoeDirector of Operations
  • Swan TufferyDirector of Research and Development & Compliance
  • Ms. Nathalie Caire RichardHuman Resources Director

Financials

Income Statement

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue15.67M18.24M21.26M27.96M22.27M24.62M36.34M37.41M27.12M24.32M31.01M32.19M36.27M35.27M44.12M46.07M50.00M
Growth (%)-+16.46%+16.55%+31.51%-20.38%+10.60%+47.58%+2.95%-27.52%-10.30%+27.49%+3.81%+12.67%-2.75%+25.08%+4.42%+8.53%
Cost of Revenue11.58M12.74M18.83M20.33M14.16M14.94M21.21M20.61M17.31M17.62M22.41M19.55M23.08M21.44M28.10M27.68M48.30M
Gross Profit4.08M5.51M2.44M7.63M8.11M9.68M15.13M16.80M9.81M6.70M8.60M12.64M13.88M13.83M16.01M18.39M1.67M
Gross Margin26.06%30.19%11.46%27.30%36.42%39.33%41.62%44.91%36.16%27.55%27.74%39.26%38.28%39.22%36.30%39.92%3.34%
Operating Expense10.35M11.03M3.39M8.85M9.08M12.07M17.99M18.40M13.44M11.89M13.04M16.00M14.72M19.71M18.28M18.74M-177.00K
Operating Income-6.26M-5.53M-952.00K-1.22M-969.00K-2.39M-2.86M-1.59M-3.64M-5.19M-4.44M-3.37M-834.00K-5.88M-2.27M-346.00K1.85M
Operating Margin-39.97%-30.29%-4.48%-4.36%-4.35%-9.70%-7.88%-4.26%-13.41%-21.35%-14.31%-10.45%-2.30%-16.66%-5.13%-0.75%3.70%
EBITDA-4.77M-4.69M-830.00K347.00K-175.00K92.00K-135.00K545.00K-2.49M-3.80M-952.00K-1.05M-364.00K-4.28M831.00K-200.00K4.21M
EBITDA Margin-30.44%-25.71%-3.90%1.24%-0.79%0.37%-0.37%1.46%-9.17%-15.63%-3.07%-3.25%-1.00%-12.13%1.88%-0.43%8.42%
Net Income-6.07M-5.84M-2.34M258.00K-971.00K-1.10M-2.68M-1.35M-850.00K-5.45M-3.24M-5.24M-3.88M-6.82M-4.95M-2.88M-167.00K
Net Income Margin-38.75%-32.04%-11.01%0.92%-4.36%-4.45%-7.37%-3.60%-3.13%-22.42%-10.44%-16.28%-10.68%-19.34%-11.21%-6.25%-0.33%
R&D----951.00K1.32M1.68M2.90M2.93M2.65M2.49M2.64M3.26M2.10M2.18M--
R&D as % of Total Revenue----4.27%5.36%4.63%7.75%10.80%10.91%8.04%8.19%8.99%5.96%4.94%--
Interest Expense140.00K219.00K137.00K35.00K21.00K182.00K53.00K93.00K77.00K79.00K175.00K934.00K382.00K225.00K456.00K2.30M1.10M
Interest Expense % of Total Revenue0.89%1.20%0.64%0.13%0.09%0.74%0.15%0.25%0.28%0.32%0.56%2.90%1.05%0.64%1.03%4.99%2.20%

Balance Sheet

Currency: EUR2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets19.93M21.63M21.07M23.16M23.57M39.40M46.42M49.98M40.08M36.84M40.28M45.80M53.03M53.89M51.14M53.95M62.52M
Total Liabilities8.15M10.47M12.17M9.17M10.10M17.39M21.15M21.71M16.73M18.96M25.44M28.75M32.59M35.72M37.42M39.79M41.85M
Total Equity11.70M11.06M8.80M13.88M13.38M20.40M24.26M24.77M23.47M18.05M14.66M17.02M18.73M15.66M12.38M12.84M19.14M
Cash2.29M5.62M1.81M3.75M5.22M5.17M5.32M5.59M1.93M-1.77M1.48M1.70M4.20M4.39M4.76M5.34M7.14M
Total Debt1.35M1.75M2.55M2.84M3.18M2.84M6.22M6.21M5.76M6.62M9.82M14.83M15.87M15.37M20.06M20.07M18.73M
Net Debt-930.00K-3.88M744.00K-910.00K-2.04M-2.34M898.00K614.00K3.84M8.39M8.35M13.13M11.67M10.98M15.30M14.73M11.59M

Cash Flow

Currency: EUR2002-12-312003-12-312007-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow----3.53M-1.10M-3.71M-1.36M479.00K-1.85M-4.27M-802.00K-3.56M-730.00K364.00K-3.69M-1.08M960.00K-1.65M3.60M-254.00K
Investing Cash Flow----774.00K-1.03M-987.00K-727.00K-912.00K-1.20M-1.43M-3.31M-2.27M-3.23M-2.29M4.62M-2.70M-3.09M-1.48M-2.90M-2.92M
Financing Cash Flow----1.20M5.63M891.00K5.58M104.00K8.57M2.62M4.66M2.33M259.00K3.40M1.04M6.24M3.08M3.48M-112.00K4.97M
Capital Expenditure000774.00K1.05M987.00K821.00K1.01M1.57M2.25M3.32M3.72M3.24M3.38M3.08M5.88M2.60M2.72M3.57M2.92M
Free Cash Flow----4.31M-2.15M-4.70M-2.18M-532.00K-3.42M-6.52M-4.12M-7.28M-3.97M-3.01M-6.77M-6.96M-1.64M-4.37M30.00K-3.17M
FCF to OCF---121.90%195.10%126.58%160.37%-111.06%185.23%152.68%513.72%204.64%543.42%-827.47%183.62%643.03%-170.31%265.59%0.83%1248.03%

Earnings

Report DateSep 30, 2013Apr 16, 2014Jul 22, 2014May 11, 2015Jul 25, 2017Feb 28, 2018May 15, 2018Aug 28, 2018Nov 15, 2018Feb 27, 2019Apr 29, 2019Jul 22, 2019Oct 23, 2019Feb 26, 2020Apr 30, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021Jun 2, 2021Sep 1, 2021Dec 1, 2021Mar 2, 2022Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 1, 2023Jun 2, 2023Jul 20, 2023Oct 19, 2023Feb 28, 2024May 29, 2024Aug 28, 2024Nov 27, 2024Apr 14, 2025Sep 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.000.000.03-0.110.00-0.110.00-0.220.00-0.110.00-0.090.000.200.00-0.550.00-0.040.00-0.170.00-0.250.000.000.000.000.000.000.000.000.00-0.06-0.01
Surprise-----------------------------------
Timing--Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hours-----------After-hoursAfter-hoursPre-market------

Key Statistics & Ratios

Market Cap23.87M
Enterprise Value43.72M
Trailing P/E46.10
Forward P/E0.00
Price / Sales0.46
Price / Book1.37
EPS0.02
Book Value0.738
Revenue (TTM)51.41M
Gross Profit (TTM)21.48M
EBITDA1.24M
Profit Margin0.87%
Operating Margin4.15%
Return on Equity4.52%
Return on Assets2.06%
Shares Outstanding25.89M
Shares Float13.66M
Beta0.68
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 21, 20161:10
  • Dec 2, 20141697:1602
  • May 9, 2012808:771
  • Oct 1, 201051:49
  • Aug 18, 200822:15
  • Sep 12, 20062140:1501